milrinone and sotalol

milrinone has been researched along with sotalol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Horowitz, JD; Ritchie, RH; Zhang, YI1
Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R1

Reviews

1 review(s) available for milrinone and sotalol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for milrinone and sotalol

ArticleYear
Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiac Complexes, Premature; Cardiotonic Agents; Female; Humans; Injections, Intravenous; Male; Metoprolol; Middle Aged; Milrinone; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Phosphodiesterase Inhibitors; Pyridones; Sotalol; Ventricular Function, Left

1995

Other Studies

4 other study(ies) available for milrinone and sotalol

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Mechanism of action of OPC-8490 in human ventricular myocardium.
    Circulation, 1996, Feb-15, Volume: 93, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine

1996